A Phase II Study Of Vinflunine In Bladder Cancer Patients Progressing ...
Vinflunine in bladder cancer – phase II trials. In 2006, Culine et al published results of a phase II study of VFL as a 10-minute infusion 3-weekly in bladder cancer patients failing or progressing after first-line platinum-containing chemotherapy or after platinum-containing regimens given with adjuvant or neoadjuvant intent (Culine et al 2006). Fifty-eight patients were recruited in this …
Vinflunine In The Treatment Of Bladder Cancer
Vinflunine, as a TCCU second-line chemotherapy, brings benefits, particularly in cases where there is no alternative treatment. Real-World Vinflunine Outcomes in Bladder Cancer in a Single-Institution Study: Moving Beyond Clinical Trials
Real-World Vinflunine Outcomes In Bladder Cancer In A …
29 rows · 24/10/2014 · A phase II study of vinflunine in bladder cancer patients progressing after first-line ...
Safety And Effectiveness Of Vinflunine In Patients With …
Vinflunine is a vinca-alkaloid that was specifically developed as second line treatment post-platinum. As of today, it is the sole anticancer agent for which clinical trials have been pushed to phase III and that was approved for patients in good conditions.
[Care Of Advanced Or Metastatic Bladder Cancer In Second …
Vinflunine in the treatment of bladder cancer. January 2009 · Therapeutics and Clinical Risk Management. Maria De Santis; Mark Bachner; Vinflunine (VFL) is a third-generation bifluorinated semi ...
(PDF) Vinflunine And Bladder Cancer: Present And Future …
Vinflunine Section VI. Chemotherapy for Metastatic Bladder Cancer. Several phase II results of second-line single agents, including... Anticancer Drugs Targeting Tubulin and Microtubules. Vincristine and vinblastine are complex molecules produced by the... Recent Advances in the Delivery of ...
Vinflunine - An Overview | ScienceDirect Topics
01/12/2015 · Intravenous vinflunine 320 mg/m 2 every 3 weeks plus best supportive care resulted in better overall survival in comparison with best supportive care alone for eligible patients with failure of prior therapy with locally advanced or metastatic transitional cell cancer of urothelial tract (TCCU). The objective of the present study was to describe our real-life …
Real-World Vinflunine Outcomes In Bladder Cancer In A …
Vinflunine appears to be a safe and effective treatment modality for relapsed urothelial cancer. More effective therapies and more accurate prognostic algorithms should be sought. a Second Oncology Department, MITERA Hospital, Maroussi. b Department of Clinical Therapeutics, Medical School.
Treatment Of Relapsed Urothelial Bladder Cancer With …
21/09/2009 · Vinflunine in metastatic bladder cancer. Vinflunine recently obtained approval by EMEA as second line chemotherapy in metastatic urothelial cancer. Since it is the first time a drug is registered in this specific indication it may lead to a change in hospital and general clinical practice.